BenQ Medical Technology and Brain Navi Join Forces for Neurosurgery Innovation in China

BenQ Medical Technology and Brain Navi Partnership in Neurosurgery

In a groundbreaking collaboration, Brain Navi Biotechnology has joined forces with BenQ Medical Technology to advance the field of neurosurgical robotics within the Chinese market. This strategic partnership aims to introduce the NaoTrac neurosurgical navigation robot, showcasing a strong commitment to integrating advanced technology into surgical practices that enhance patient care and outcomes.

Revolutionizing Neurosurgery with NaoTrac

The NaoTrac system represents a significant leap forward in neurosurgical navigation, employing cutting-edge AI technology to ensure precision in surgical procedures. This collaboration aligns with Brain Navi's globalization goals set for 2025, emphasizing partnerships that cater to local market needs while accelerating the deployment of its innovative systems.

China's surgical robotics industry is projected to soar, with estimates suggesting the market might exceed USD 3 billion by 2026, and reach around USD 9.5 billion by 2030 according to Frost Sullivan. The increased demand for neurosurgical precision and automation highlights the essential role that NaoTrac is poised to play in improving clinical outcomes for patients.

As part of this partnership, BenQ Medical Technology plans to utilize its extensive network of hospitals across China to implement NaoTrac effectively, aligning with national initiatives that promote innovation in medical equipment. The country’s current medical development framework aims to boost the domestic market and advance intelligent medical solutions, making this collaboration timely and relevant.

Commitment to Intelligent Healthcare

Michael Kuan, President of BenQ Medical Technology, emphasized the critical nature of this partnership, stating it marks a pivotal step towards integrating surgical robotics into smart operating rooms. The rapid evolution of AI and robotic technologies is shaping the future of healthcare, and through this collaboration, both companies are committed to fostering the adoption of surgical robotics within China, delivering innovative and safe surgical solutions.

Dr. Jerry Chen, CEO of Brain Navi, underscored the importance of localized partnerships in their strategy. He noted that NaoTrac has already been successfully employed in multiple regions including Asia, Latin America, and Europe. The collaboration with BenQ Medical Technology offers a robust entry point into the Chinese healthcare market, where localization is paramount for successful integration and adoption.

This partnership is an integral part of Brain Navi's broader strategy to enhance its global footprint, focusing on regions like EMEA, Asia-Pacific, and Latin America. The company strives to provide localized support through distributor and hospital collaborations, as well as advanced surgeon training tailored to their needs. Ensuring a seamless integration of neurosurgical robotics into regional healthcare systems is a key objective for Brain Navi.

Showcasing Innovation at AANS 2025

Brain Navi is set to showcase the NaoTrac system at the upcoming American Association of Neurological Surgeons (AANS) Annual Meeting on April 25–28, 2025, in Boston, Massachusetts. This event provides a unique opportunity for distributors, hospitals, and neurosurgeons to witness firsthand the future landscape of neurosurgical robotics driven by advanced technology.

About BenQ Medical Technology

BenQ Medical Technology, part of the BenQ Group, is recognized globally for its advanced medical devices and innovative healthcare solutions. Founded in 1989, the company has established a strong reputation for high-quality surgical equipment and patient care systems, with certifications like ISO 13485 and ISO 9001 underscoring its commitment to excellence. Through technology and strategic collaborations, BenQ is continually advancing its contributions to healthcare and patient outcomes worldwide.

About Brain Navi

Brain Navi Biotechnology is at the forefront of innovation in surgical robotics, specializing in robotic surgery and navigation technologies. Its proprietary Surface Mapping Auto-Registration Technology (SMART) integrates artificial intelligence, robotics, and machine vision to streamline surgical processes while ensuring minimal invasiveness. NaoTrac's efficient navigation system aids surgeons in planning surgical trajectories with precision and provides real-time imaging to enhance surgical accuracy.

In conclusion, the partnership between BenQ Medical Technology and Brain Navi represents a pivotal movement toward ushering in a new era of neurosurgical practices, driven by the potential of robotics and artificial intelligence to redefine patient care and surgical outcomes in China.